Novartis said profit fell in the first quarter as it pumped investment into the launch of its new heart-failure drug Entresto that it hopes will help offset revenue lost as best-selling cancer medicine Gleevec loses out to cheaper competitors.
from WSJ.com: US Business http://ift.tt/2oFYK5l
via IFTTT
No comments:
Post a Comment